Walgreen Co.'s fiscal second-quarter earnings fell almost 8 percent, knocked down largely by its exit from the Express Scripts pharmacy network, but the drugstore operator still topped analyst expectations, and its shares outperformed broader market indexes Tuesday.

The nation's largest drugstore chain said its split with Express Scripts, a St. Louis-based pharmacy benefits manager, hurt results by about 7 cents per share in the quarter that ended Feb. 29. A mild cold and flu season also affected earnings by about 3 cents per share.

Express Scripts paid Walgreen to fill prescriptions, but the companies let a contract between them expire at the end of last year after months of talks failed to produce a new deal. Pharmacy benefits managers, or PBMs, run prescription drug plans and use large purchasing power to negotiate lower drug prices.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.